BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

NEXT STORY
Phase 2b VITAL study of Gemogenovatucel-T (Vigil™) immunotherapy demonstrates clinical benefit in homologous recombination (HR) proficient ovarian cancer
PREV STORY
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Electrosurgery Devices Markets, 2020-2026 – Focus on Generators, Instruments, Accessories, & Argon and Smoke Management Systems

author_avatar
NASDAQ Market News

Alimera Sciences Meets Revenue Milestone and Accesses Additional $2.5 Million Under Solar Debt Agreement

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients

author_avatar
NASDAQ Market News